Published in Drug Law Weekly, April 25th, 2006
This enormous redirection of funds into the healthcare system has the potential to disrupt the status quo within the pharmaceutical industry, creating new winners and losers. Success in the geriatric drug arena will require a detailed mastery of the new rules, a nimble approach to partnering, and the ability to respond rapidly to inevitable changes in the regulations, according to Research and Markets' report, Opportunities and...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Drug Law Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.